Health Care Archives - Page 44 of 478

1 minute read

Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday?

April 10, 3:07 PM

Alpine Immune Sciences explores strategic options, potentially selling amid interest from buyers. The Seattle-based firm, with soaring stock up over 400%, evaluates various possibilities.

ALPN

2 minute read

Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck’s Pneumococcal Shots – Analyst Says

By Vandana Singh

April 10, 2:42 PM

The global PCV market, valued at ~$8 billion annually, is poised for significant growth, estimated to reach ~$12 billion soon. Market dynamics are shifting towards adults, potentially doubling with the US discussing vaccination age reduction. Prevnar20 dominates with 97% market share in adults, but Vaxcyte's advanced conjugate capabilities present a competitive advantage.

MRK

2 minute read

Cartesian Therapeutics’ Rare Disease Candidate Shows Long Lasting Benefit Over Argenx’s Vyvgart, Analyst Initiates With Buy

By Vandana Singh

April 10, 2:34 PM

Cartesian Therapeutics' autoimmune disease treatment with re-dosable mRNA CAR-Ts. Learn about Descartes-08, a promising anti-BCMA CAR-T therapy offering deeper, longer-lasting efficacy than current standards. Analysts project substantial market capture and peak sales potential.

ARGX

1 minute read

GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings

By Priya Nigam

April 10, 12:10 PM

GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.

GDRX

1 minute read

Kill Leukemia Cells While Preserving Healthy Tissues: Nano-Cap Cancer Focused Firm IN8bio’s Preclinical Candidate Shows Potential

By Vandana Singh

April 10, 10:38 AM

IN8bio's nsCAR platform, INB-300. Presented at AACR 2024, new preclinical data highlights its superior selectivity in targeting leukemia cells while sparing healthy tissue. Experience a potential wider therapeutic window without compromising efficacy.

INAB

2 minute read

Why Is European Healthcare Tech Giant Philips Stock Trading Higher On Wednesday?

By Vandana Singh

April 10, 9:47 AM

Philips has finalized an agreement with US authorities and the FDA regarding the recall of Respironics ventilators. Consent decree mandates remediation prioritization and operational focus in the US. Business outlook and financial guidance remain stable.

PHG

2 minute read

EXCLUSIVE: Adial Pharmaceuticals’ Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance

By Vandana Singh

April 10, 8:00 AM

Adial Pharmaceuticals releases a peer-reviewed article on AD04, its lead investigational drug for Alcohol Use Disorder. The study highlights a strong safety profile & liver safety compared to a placebo.

ADIL

2 minute read

Why Jaguar Health Stock Is Soaring After-Hours

By Erica Kollmann

April 9, 4:51 PM

Jaguar Health reported all proposals were approved by stockholders, and the company will not be implementing a reverse split at this time.

JAGX

2 minute read

Chinese Biotech YS Biopharma’s Next-Gen Rabies Vaccine Non-Inferior To Approved Competitor

By Vandana Singh

April 9, 3:30 PM

YS Biopharma unveils interim results from Phase 3 trial of PIKA Rabies Vaccine, meeting primary endpoints. With accelerated immunity in 7 days, it could revolutionize rabies prevention.

2 minute read

Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says

By Vandana Singh

April 9, 2:26 PM

Mizuho Securities initiates coverage on Enliven Therapeutics. Expectations high for late 2024 Phase 1 results. Enliven poised to revolutionize CML treatment, addressing current TKI limitations. Mizuho bullish with Buy rating, $34 price target. ELVN's trading value suggests conservative estimation compared to CML market potential.

ELVN